ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.972,28
0,37%
S&P 500
5.064,20
0,91%
Dow Jones
38.225,66
0,85%
Euro vs US Dollar
1,07477
0,17%
Bitcoin
59.132,58
0,02%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Catalyst Pharmaceuticals Inc (CPRX)

  7. Catalyst Pharmaceuticals Inc (CPRX) News

CPRX Catalyst Pharmaceuticals Inc

15,02
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 13:00:12
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Catalyst Pharmaceuticals Inc CPRX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 15,02 13:00:12
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
15,02
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202414:00GLOBECatalyst Pharmaceuticals to Participate at the BofA..
22.4.202414:00GLOBECatalyst Pharmaceuticals to Report First Quarter 2024..
28.3.202413:03GLOBECatalyst Pharmaceuticals Announces Support for the Inaugural..
27.3.202413:03GLOBECatalyst Pharmaceuticals to Participate in the 2024 Cantor..
13.3.202412:55GLOBECatalyst Pharmaceuticals Announces AGAMREE® Now Commercially..
05.3.202414:03GLOBECatalyst Pharmaceuticals to Participate at the Barclays 26th..
29.2.202400:03GLOBECatalyst Pharmaceuticals Reports Strong Fourth Quarter and..
27.2.202414:03GLOBECatalyst Pharmaceuticals to Present at MDA Clinical &..
21.2.202415:00GLOBECatalyst Pharmaceuticals Announces Publication of Santhera..
16.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202414:03GLOBECatalyst Pharmaceuticals to Report Fourth Quarter and..
09.1.202423:15EDGAR2Form 8-K - Current report
09.1.202422:05GLOBECatalyst Pharmaceuticals, Inc. Announces Closing of Public..
08.1.202414:10EDGAR2Form 8-K - Current report
05.1.202423:23EDGAR2Form 8-K - Current report
05.1.202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05.1.202414:02GLOBECatalyst Pharmaceuticals, Inc. Announces Pricing of Public..
04.1.202422:49GLOBECatalyst Pharmaceuticals, Inc. Announces Proposed Public..
03.1.202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202423:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
29.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202322:30EDGAR2Form 8-K - Current report
18.12.202312:30GLOBECatalyst Pharmaceuticals Announces FIRDAPSE® New Drug..
15.12.202319:47EDGAR2Form 144 - Report of proposed sale of securities
13.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202320:57EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
CPRX
Catalyst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten